Which grant program conducted by the ACS focuses on immunotherapy and immune responses?

The choice that focuses on immunotherapy and immune responses is indeed the program related to Clinical Cancer Research, Nutrition, and Immunology. This program is specifically designed to support research that enhances the understanding and development of treatments aimed at harnessing the body's immune system to fight cancer, which is a pivotal area in modern oncology. Immunotherapy has become a cornerstone of cancer treatment, and this program aims to advance research in this field, ensuring that new therapies can be effectively developed and utilized in clinical practice.

The other programs, while essential to cancer research and treatment, do not specifically target immune responses or immunotherapy as their primary focus. The Cancer Control and Prevention Research program is more concerned with strategies to reduce cancer incidence and mortality through prevention and early detection. Health Professional Training in Cancer Control emphasizes educating healthcare professionals on various cancer control strategies but does not prioritize immunology or therapies specifically targeting immune responses. The Translational Cancer Research program typically bridges the gap between lab research and clinical application, but it encompasses a broader range of cancer research domains beyond just immunotherapy.